Alik Farber, MD, Kevin Major, MD, Willis H Wagner, MD, J

Slides:



Advertisements
Similar presentations
Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 
Advertisements

Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: An analysis of 1275 cases 
Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 
Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D. 
Autologous alternative veins may not provide better outcomes than prosthetic conduits for below-knee bypass when great saphenous vein is unavailable 
Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease?  Marc A. Passman,
The current position of precuffed expanded polytetrafluoroethylene bypass grafts in peripheral vascular surgery  Jasper van der Slegt, MD, Stijn L. Steunenberg,
Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD 
Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage  Caren Randon, MD, Bart Jacobs, MD, Frederik.
A comparative study of alternative conduits for lower extremity revascularization: All- autogenous conduit versus prosthetic grafts  Peter L. Faries, MDa,
The impact of gender on outcome after infrainguinal arterial reconstructions for peripheral occlusive disease  Enzo Ballotta, MD, Mario Gruppo, MD, Renata.
Cryopreserved arterial allograft reconstruction for peripheral graft infection  Yves Castier, MD, Fady Francis, MD, Pierre Cerceau, MD, Mathieu Besnard,
Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.
Insulin use is associated with poor limb salvage and survival in diabetic patients with chronic limb ischemia  Hasan H. Dosluoglu, MD, Purandath Lall,
Gerald S. Treiman, MD, Richard L. Treiman, MD, Robert F
Return to well-being and function after infrainguinal revascularization  Gary W. Gibbons, MD, Anne M. Burgess, RN, Edward Guadagnoli, PhD, Frank B. Pomposelli,
Axillopopliteal bypass for limb salvage
Edmond J. Prendiville, MB, FRCSI, Anson Yeager, MD, Thomas F
Bruce D. Misare, MD, Frank B. Pomposelli, MD, Gary W
Infrainguinal revascularizations in octogenarians and septuagenarians
Cryopreserved saphenous vein graft in infrainguinal bypass
Percutaneous intervention for infrainguinal occlusive disease in women: Equivalent outcomes despite increased severity of disease compared with men  Brian.
Carla C. Moreira, MD, Alexander D
Dorsalis pedis arterial bypass: Durable limb salvage for foot ischemia in patients with diabetes mellitus  Frank B. Pomposelli, MD, Edward J. Marcaccio,
Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass  James T. McPhee, MD, Neal R. Barshes, MD,
Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions  Gautam V. Shrikhande, MD,
Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial.
Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization  William A. Marston, MD, Stephen W. Davies,
Lower extremity arterial reconstruction for critical limb ischemia in diabetes  Enzo Ballotta, MD, Antonio Toniato, MD, Giacomo Piatto, MD, Franco Mazzalai,
Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure  Vincent J. Santo, MD, Phong.
Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures  Hans Schweiger, MD,
A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease  Norman R.
A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical.
Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia 
Infrainguinal arterial reconstruction for claudication: Is it worth the risk? An analysis of 409 procedures  John Byrne, MD, R.Clement Darling III, MD,
Factors affecting the patency of infrainguinal bypass
Long-term outcome after early infrainguinal graft failure
Balloon angioplasty for revision of failing lower extremity bypass grafts  Haitham Ali, MD, Ahmed Elbadawy, MD, Mahmoud Saleh, MD, Ayman Hasaballah, MD 
Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial 
Bypass in the absence of ipsilateral greater saphenous vein: Safety and superiority of the contralateral greater saphenous vein  David K.W. Chew, MD,
Comparison of contrast arteriography to arterial mapping with color-flow duplex imaging in the lower extremities  David V. Cossman, MD, Jean E. Ellison,
Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency  Carlos Eduardo Pereira, MD, Maximiano Albers, MD, PhD, Marcello.
Long-term assessment of cryopreserved vein bypass grafting success
Anthony D. Whittemore, MD, Magruder C. Donaldson, MD, John A
Treatment of recurrent femoral or popliteal artery stenosis after percutaneous transluminal angioplasty  Gerald S. Treiman, MD*, Laura Ichikawa, BS‡,
A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb  Herbert Dardik, M.D., Normand.
Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts  C.J. Buckley, MD, S. Abernathy,
Composite sequential bypasses to the ankle and beyond for limb salvage
Carlos H. Timaran, MD, Scott L. Stevens, MD, Oscar H
Compromised bypass graft outcomes after minimal-incision vein harvest
Peripheral vascular bypass in juvenile-onset diabetes mellitus: Are aggressive revascularization attempts justified?  Christopher J. Kwolek, MD, Frank.
Robert W. Harris, MD, Peter A
A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions 
James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD 
Isolated profundaplasty for limb salvage
Early experience with cryopreserved saphenous vein allografts as a conduit for complex limb-salvage procedures  Philip J. Walker, FRACS, R.Scott Mitchell,
A metropolitan experience with infrainguinal revascularization
Efficacious use of nitinol stents in the femoral and popliteal arteries  Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD 
Prospective randomized study on bilateral above-knee femoropopliteal revascularization: polytetrafluoroethylene graft versus reversed saphenous vein 
Stephen Kolakowski, MD, Matthew J Dougherty, MD, Keith D Calligaro, MD 
Homologous veins as an arterial substitute: Long-term results
Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: An analysis of 1275 cases 
Long-term results of arterial allograft below-knee bypass grafts for limb salvage: A retrospective multicenter study  J.N. Albertini, MD, X. Barral, MD,
Limb salvage after infrainguinal bypass graft failure
Randomized comparison of 6-mm straight grafts versus 6- to 8-mm tapered grafts for brachial-axillary dialysis access  Jose R. Polo, MD, PhD, Jose M. Ligero,
Luke S. Erdoes, MD, Timothy P. Milner, MD  Journal of Vascular Surgery 
Benjamin B. Chang, MD, R. Clement Darling, MD, Devon E. M
Endovascular-assisted versus conventional in situ saphenous vein bypass grafting: Cumulative patency, limb salvage, and cost results in a 39-month multicenter.
Lessons learned in adopting the in situ saphenous vein bypass
Superficial femoral artery eversion endarterectomy: A useful adjunct for infrainguinal bypass in the presence of limited autogenous vein  Spence M. Taylor,
Presentation transcript:

Cryopreserved saphenous vein allografts in infrainguinal revascularization: analysis of 240 grafts  Alik Farber, MD, Kevin Major, MD, Willis H Wagner, MD, J.Louis Cohen, MD, David V Cossman, MD, Stephen R Lauterbach, MD, Philip M Levin, MD  Journal of Vascular Surgery  Volume 38, Issue 1, Pages 15-21 (July 2003) DOI: 10.1016/S0741-5214(03)00330-6

Fig 1 Indications for 199 primary revascularization procedures with Cryografts. Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)

Fig 2 Categorization of 127 secondary procedures after primary revascularization with Cryografts. TPA, Tissue plasminogen activator. Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)

Fig 3 Primary patency curve and life table for 199 primary revascularization procedures with Cryografts. Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)

Fig 4 Comparison of primary patency rates in grafts with below-knee popliteal (black line) and infrapopliteal (gray line) distal anastomosis (P = NS; Cox multivariate regression analysis). Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)

Fig 5 Effect of diabetes on primary Cryograft patency (P < .05; log-rank test). Gray line, Diabetes; black line, no diabetes. Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)

Fig 6 Limb salvage curve and life table for 199 limbs after primary Cryograft revascularization. Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)

Fig 7 Effect of below-knee popliteal (black line) and infrapopliteal (gray line) distal Cryograft anastamosis on limb salvage (P < .05; log-rank test). Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)